CERRAPINI LIMITED

Company Registration Number:
07999174 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

CERRAPINI LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

CERRAPINI LIMITED

Company Information

for the Period Ended 31 March 2024




Director: Heather Blake
Registered office: 19
Spencer Square
Ramsgate
Kent
England
CT11 9LA
Company Registration Number: 07999174 (England and Wales)

CERRAPINI LIMITED

Balance sheet

As at 31 March 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 1,174 0
Total fixed assets: 1,174 0
Current assets
Stocks: 6,339 5,969
Debtors: 5 116 0
Cash at bank and in hand: 1,765 11,015
Total current assets: 8,220 16,984
Creditors: amounts falling due within one year: 6 ( 10,420 ) ( 14,690 )
Net current assets (liabilities): ( 2,200 ) 2,294
Total assets less current liabilities: ( 1,026 ) 2,294
Total net assets (liabilities): ( 1,026 ) 2,294

The notes form part of these financial statements

CERRAPINI LIMITED

Balance sheet continued

As at 31 March 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: ( 1,126 ) 2,194
Shareholders funds: ( 1,026 ) 2,294

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 17 October 2024
And Signed On Behalf Of The Board By:

Name: Heather Blake
Status: Director

The notes form part of these financial statements

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 3. Off balance sheet disclosure

    No

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible assets

Plant & machinery Total
Cost £ £
At 01 April 2023 5,942 5,942
Additions 1,761 1,761
Disposals - -
Revaluations - -
Transfers - -
At 31 March 2024 7,703 7,703
Depreciation
At 01 April 2023 5,942 5,942
Charge for year 587 587
On disposals - -
Other adjustments - -
At 31 March 2024 6,529 6,529
Net book value
At 31 March 2024 1,174 1,174
At 31 March 2023 0 0

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Debtors


2024
£

2023
£
Trade debtors 116 0
Total 116 0

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

6.Creditors: amounts falling due within one year note


2024
£

2023
£
Accruals and deferred income 750 950
Other creditors 9,670 13,740
Total 10,420 14,690